At SRS we firmly believe that the right people, the right environment and the right tools result in the best and most innovative health solutions. With over two decades of experience formulating high quality products and commercialising innovative drug delivery systems for companies large and small around the world, we bring great perspective to improving product access, improving patient compliance and enhancing patient care.
We deal in finished formulations, therapies and technologies but our passion lies in taking on the most complex problems and making things simple. We are passionate about ideas and making a real impact on the consumer’s quality of life.
To be one of the most innovative life sciences companies in the world.
To create better lives for as many people as possible by bringing them innovative, high-quality and much needed drugs and therapies, through our three business verticals, research capabilities and talented people.
Our Therapies business focuses on developing and commercialising effective therapeutic solutions to treat diseases and autoimmune disorders. We identify and collaborate with world-class innovator companies, scientists and health care practitioners to commercialise life-changing products and create powerful brands under the SRS name.
Finished Dosage Formulations
Our Finished Dosage Formulations business is a broad portfolio of innovative and established medicines. Leveraging our people, market intelligence, global and local presence, R&D capabilities and strong ties with manufacturers, we produce and sell finished formulations to institutional and private clients in both emerging and regulated countries.
Our Technologies business boasts a range of novel drug delivery systems such as our Unistraw Delivery System and Hydrogels. We collaborate and partner with companies to vastly improve compliance and enhance bioavailability of their formulations.